Back to mobile site

Cowen Reiterates Outperform Rating on Outset Medical Inc. (OM), Comments on FDA Clearance

August 1, 2022 8:58 AM EDT Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $33.00 price target on Outset Medical Inc. (NASDAQ: OM).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login